Xcout Intel
PinkDx, Inc.
PinkDx, Inc., also known as The Gyne Cancer Company, is headquartered in San Francisco, California. The company specializes in advanced gynecologic cancer diagnostics and developing innovative patient testing solutions.
Subscribe to see PinkDx, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
PinkDx, Inc. at a glance
PinkDx, Inc. is a life sciences company headquartered in United States. Its most recent funding round, Series A, raised $45M in January 2025. Xcout tracks 10 named people at PinkDx, Inc., including Richard T. Kloos, M.D. (Chief Medical Officer).
PinkDx, Inc. leadership
- Richard T. Kloos, M.D.Chief Medical Officer
- Bonnie AndersonCo-Founder, Chair, and Chief Executive Officer
- Tim McMeekancofounder, chief financial officer and chief business office
- Timothy McMeekanCo-Founder, Chief Financial Officer, and Chief Business Officer
- Giulia C Kennedycofounder and chief scientific officer
- Giulia Kennedy, Ph.D.Co-Founder and Chief Scientific Officer
4 more named people on record for PinkDx, Inc., with roles, board committees and tenure — see the full roster →
PinkDx, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $45M | 9 named | |
| Series A | $40M | 3 named | |
| SEC Form D filing | $17M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
PinkDx, Inc. competitors
A few of PinkDx, Inc.'s closest competitors — see the full list of competitors and alternatives →
Hera Therapeutics Inc. is a women's health diagnostics company that develops non-invasive, AI-powered tools for the detection and staging of endometriosis and cervical cancer. The company serves patients and clinicians in OB-GYN, fertility, and drug discovery fields by providing molecular tests and point-of-care diagnostic devices designed to replace invasive procedures.
Nevia Bio is an Israel-based biotechnology and health technology company, formerly known as Gina Life, that develops AI-driven diagnostic platforms. The company focuses on creating non-invasive early detection tests for gynecologic cancers, specifically ovarian cancer, by analyzing vaginal fluid.
QuanDx, Inc. is a healthcare and medicine company providing products and research related to fusion genes and diagnostics, with its headquarters in San Jose, California.
Biodesix, Inc. is a public diagnostic solutions company founded in 2006 and headquartered in Louisville, Colorado. The company specializes in diagnostic testing and development services focused on discovering blood-based tests for cancer management.
Avant Diagnostics, Inc. is an oncology-focused healthcare data and medical diagnostic technology company headquartered in Washington, United States, dedicated to commercializing solutions for early cancer detection.
Protean BioDiagnostics Inc. is a diagnostic company based in the United States that provides advanced cancer profiling systems and laboratory testing services.
Get PinkDx, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on PinkDx, Inc. in Xcout Intel
- 10 named people with titles, LinkedIn and board committees
- 3 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access